LifeStance Health Group, Inc. (LFST) intrinsic value & 10-year financials
LifeStance Health Group, Inc. (LFST) has a Graham intrinsic value of $0.82 per share. At $11.74 on Oct 17, 2026, the stock trades 1332% above that value. Over the last 8 fiscal years revenue grew 37.3% a year to $1.4B, with an average return on invested capital of -7.9%.
- Graham intrinsic value
- $0.82
- Share price (Oct 17, 2026)
- $11.74
- Price vs Graham value
- 1332% above
- Market cap
- $4.6B
- Revenue (FY2025)
- $1.4B
- Revenue growth (8-yr CAGR)
- 37.3%
- ROIC (10-yr avg)
- -7.9%
- Free cash flow (FY2025)
- $110.0M
LFST 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.4B | $9.7M | — | $110.0M | 1.7% | 1.1% |
| FY2024 | $1.3B | -$57.4M | — | $85.7M | -2.5% | -1.8% |
| FY2023 | $1.1B | -$186.3M | — | -$57.4M | -17.9% | -9.3% |
| FY2022 | $859.5M | -$215.6M | — | -$26.5M | -24.5% | -11.4% |
| FY2021 | $1.4M | -$307.2M | — | -$85.1M | -19816.8% | -18.2% |
| FY2020 | — | — | — | — | — | — |
| FY2019 | $212.5M | $5.7M | — | $2.7M | 7.2% | -8.0% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
LifeStance Health Group, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
LifeStance Health Group, Inc. has historically struggled to out-earn its cost of capital, averaging just -7.9% ROIC.
LifeStance Health Group, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, LifeStance Health Group, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.82 per share.